Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascular effects of hormone therapy in symptomatic vs asymptomatic postmenopausal women
2004-005091-16Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jan 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of medroxyprogesterone acetate + estradiol, estradiol valerate + medroxyprogesterone acetate, estradiol, estradiol valerate and medroxyprogesterone acetate in vasomotor symptoms, vaginal atrophy and osteoporosis (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Pulse wave analysis. Started Jan 2005; status: completed.
02
Drugs
medroxyprogesterone acetate + estradiolestradiol valerate + medroxyprogesterone acetateestradiolestradiol valeratemedroxyprogesterone acetate
03
Conditions
vasomotor symptomsvaginal atrophyosteoporosis
Beyond the preview
Go deeper on 2004-005091-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005091-16.